Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeometals Regulatory News (NMT)

Share Price Information for Neometals (NMT)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £26.93m
NMT Live PriceLast checked at - London Stock Exchange

Intraday Neometals Share Chart

Director/PDMR Dealings

9 Jul 2024 09:59

RNS Number : 6836V
Neometals Ltd
09 July 2024
 

9 July 2024

Neometals Ltd

("Neometals" or "the Company")

Director / PDMR Dealings

Sustainable process technology developer, Neometals Ltd (ASX: NMT & AIM: NMT) ("Neometals" or "the Company") advises that a total of 1,066,459 performance rights (Performance Rights) have been granted to Non-Executive Directors (NEDs) under the Company's Performance Rights Plan (PRP), as approved by shareholders on 25 November 2022.

Under the PRP, each NED (or their nominee) is eligible to apply for the grant of Performance Rights that represents up to 50% their FY25 Director's fees, divided by the daily volume-weighted average market price (VWAP) of the Company's shares traded on the Australian Securities Exchange during the five trading days prior to the closing date of the offer (5 July 2024).

The number of Performance Rights granted to NEDs is set out below:

Non-Executive Director

FY2025 Sacrificed (AUD)

Number of Performance Rights Granted

Steven Cole

60,000 (36%)

673,553

Douglas Ritchie

25,000 (25%)

280,647

Les Guthrie

10,000 (10%)

112,259

Each Performance Right entitles the holder to a fully paid ordinary share in the Company at no cost. Performance Rights will vest on 30 June 2025 and vested Performance Rights are exercisable on or before 30 June 2026.

The updated interests of the NEDs (following issue of 1,066,459 Performance Rights pursuant to the PRP) in the share capital of the Company are as follows:

PDMR

New performance rights

Vested performance rights

Total performance rights*

Total shares (direct and indirect)

Steven Cole

 673,553

162,809

 836,362

2,257,055

Douglas Ritchie

 280,647

91,175

 371,822

426,162

Les Guthrie

 112,259

25,236

 137,495

267,066

*Includes both vested and unvested PRP Performance Rights which remain subject to vesting conditions.

As a result of the issue of the Performance Rights to the NEDs pursuant to the Company's PRP, the Company has the following securities on issue:

· 623,231,428 fully paid ordinary shares.

· 8,259,274 performance rights issued pursuant to the terms of the PRP, comprising:

400,157 vested performance rights, which remain subject to exercise; and

7,859,117 unvested performance rights, which are subject to performance testing in accordance with their terms of issue.

The above figure of 623,231,428 ordinary shares on issue may be used by shareholders as the denominator for calculations when determining if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Authorised on behalf of Neometals by Jason Carone, Company Secretary

 

ENDS

 

For more information, please contact:

 

Neometals Ltd

Chris Reed, Chief Executive Officer

 +61 8 9322 1182

Jeremy McManus

 +61 8 9322 1182

 

 

Cavendish Capital Markets Limited - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

 

About Neometals

Neometals facilitates sustainable critical material supply chains and reduces the environmental burden of traditional mining in the global transition to a circular economy.

The Company is commercialising a portfolio of sustainable processing solutions that recycle and recover critical materials from high-value waste streams.

· Neometals' core focus is its patented, Lithium-ion Battery ("LiB") Recycling technology (50% NMT), being commercialised in a 50:50 incorporated JV (Primobius GmbH) with 150-year-old German plant builder, SMS group GmbH. Primobius is supplying Mercedes-Benz a 2,500tpa recycling plant and operates its own LiB Disposal Service in Germany. Primobius' first 21,000tpa commercial plant will be offered to Stelco under an existing technology licence for North America.

Neometals is developing two advanced battery materials technologies for commercialisation under low-risk, low-capex technology licensing business models:

· Lithium Chemicals (70% NMT) - Patented ELi™ electrolysis process, co-owned 30% by Mineral Resources Ltd, to produce battery quality lithium hydroxide from brine and/or hard-rock feedstocks at lowest quartile operating costs. Pilot scale test work and Engineering Cost Study update planned for completion in DecQ 2024; and

· Vanadium Recovery (100% NMT) - Patent pending hydrometallurgical process to produce high-purity vanadium pentoxide from steelmaking by-product ("Slag") at lowest-quartile operating cost and carbon footprint.

 

Additionally, Neometals is conducting due diligence on acquiring a proprietary process and pilot plant to produce precious metals from waste.

For further information visit www.neometals.com.au

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

 1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Steven Cole 

 2. 

Reason for the notification

a)

Position/status:

Non-Executive Director 

b)

Initial notification/Amendment:

Initial Notification

 3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Neometals Ltd 

b)

LEI:

254900WO0PDVL8V1PY78 

 4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Performance Rights

 

AU000000NMT1 

b)

Nature of the transaction:

Grant of Performance Rights

 

c)

Price(s) and volume(s):

Price

Volume

Nil

673,553

d)

Aggregated information:

Aggregated volume:

Price:

N/A

 

e)

Date of the transaction:

8 July 2023

 

f)

Place of the transaction:

Off Market

 

 

 1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Douglas Ritchie

 2. 

Reason for the notification

a)

Position/status:

Non-Executive Director 

b)

Initial notification/Amendment:

Initial Notification

 3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Neometals Ltd 

b)

LEI:

254900WO0PDVL8V1PY78 

 4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Performance Rights

 

AU000000NMT1 

b)

Nature of the transaction:

Grant of Performance Rights

 

c)

Price(s) and volume(s):

Price

Volume

Nil

280,647

d)

Aggregated information:

Aggregated volume:

Price:

N/A

 

e)

Date of the transaction:

8 July 2023

 

f)

Place of the transaction:

Off Market

 

 

 1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Les Guthrie

 2. 

Reason for the notification

a)

Position/status:

Non-Executive Director 

b)

Initial notification/Amendment:

Initial Notification

 3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Neometals Ltd 

b)

LEI:

254900WO0PDVL8V1PY78 

 4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Performance Rights

 

AU000000NMT1 

b)

Nature of the transaction:

Grant of Performance Rights

 

c)

Price(s) and volume(s):

Price

Volume

Nil

112,259

d)

Aggregated information:

Aggregated volume:

Price:

N/A

 

e)

Date of the transaction:

8 July 2023

 

f)

Place of the transaction:

Off Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVKLBBZDLEBBD
Date   Source Headline
3rd Feb 20257:00 amRNSCancellation - Neometals Ltd
23rd Jan 20257:01 amRNSQuarterly Activities Report
23rd Jan 20257:01 amRNSQuarterly Cashflow
17th Jan 20257:00 amRNSCancellation of Performance Rights
20th Dec 20247:00 amRNSProposed Cancellation of Admission to AIM
6th Dec 20247:00 amRNSDirector/PDMR Dealings
22nd Nov 20249:09 amRNSResult of Annual General Meeting
22nd Nov 20247:42 amRNSChairman’s AGM 2024 Address
18th Nov 20241:14 pmRNS2024 Annual General Meeting Broadcast
12th Nov 20247:00 amRNSPositive Results from ELi™ Pilot Trial
8th Nov 20249:24 amRNSDirector / PDMR Participation in Entitlement Offer
7th Nov 202410:16 amRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSResults of Entitlement Offer
24th Oct 20247:01 amRNSQuarterly Activities Report
24th Oct 20247:01 amRNSQuarterly Cashflow
22nd Oct 20247:00 amRNSMercedes Benz Plant Opening
21st Oct 20247:00 amRNSNotice of Annual General Meeting
21st Oct 20247:00 amRNSEntitlement Offer Opens
18th Oct 20247:00 amRNSDirector/PDMR Dealings
14th Oct 20249:49 amRNSPosting of Annual Report
11th Oct 20247:00 amRNSA$4 Million Placement and Entitlement Offer
9th Oct 20247:00 amRNSASX Trading Halt
30th Sep 20247:50 amRNSResult of EGM
26th Sep 20248:56 amRNSAnnual Financial Report
23rd Sep 20247:00 amRNSBarrambie Gold Exploration Target
20th Sep 20247:00 amRNSAGM Update
16th Sep 20247:00 amRNSVRP receives EU supported capital injection
27th Aug 202410:02 amRNSNotice of EGM
22nd Aug 20247:00 amRNSNeometals Strategy Update
22nd Aug 20247:00 amRNSPrecious Metals Recovery Option Lapse
19th Aug 20247:00 amRNSUS$3M Placement
16th Aug 20247:00 amRNSResults of Extraordinary General Meeting
7th Aug 20247:00 amRNSCorporate Presentation
30th Jul 20247:19 amRNSQuarterly Activities Report
30th Jul 20247:15 amRNSQuarterly Cashflow
17th Jul 20248:36 amRNSNotice of Extraordinary General Meeting
11th Jul 20247:12 amRNSAppointment of Company Secretary
9th Jul 20249:59 amRNSDirector/PDMR Dealings
4th Jul 202411:59 amRNSIssue of Shares
27th Jun 202410:26 amRNSDirector Change
6th Jun 20248:34 amRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSPrecious Metals Due Diligence Update
3rd Jun 20247:00 amRNSAppointment of Chief Financial Officer
29th May 20247:00 amRNSNeometals Strengthens its Senior Management Team
28th May 20247:00 amRNSOption to acquire Precious Metals Process & Plant
22nd May 20247:00 amRNSFinal Stage of ELi™ Pilot Trial Commences
15th May 202412:38 pmRNSNeometals Shares Commence Trading on OTCQX market
24th Apr 20247:01 amRNSQuarterly Cashflow Report
24th Apr 20247:00 amRNSQuarterly Activities Report
18th Apr 202410:24 amRNSChange in Substantial Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.